- Home
- WULF vs NVAX Comparison
WULF vs NVAX Comparison
Compare WULF & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- NVAX
- Stock Information
- Founded
- WULF 1952
- NVAX 1987
- Country
- WULF United States
- NVAX United States
- Employees
- WULF N/A
- NVAX N/A
- Industry
- WULF EDP Services
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WULF Technology
- NVAX Health Care
- Exchange
- WULF Nasdaq
- NVAX Nasdaq
- Market Cap
- WULF 1.6B
- NVAX 2.0B
- IPO Year
- WULF 1995
- NVAX 1995
- Fundamental
- Price
- WULF $6.95
- NVAX $9.90
- Analyst Decision
- WULF Strong Buy
- NVAX Buy
- Analyst Count
- WULF 8
- NVAX 6
- Target Price
- WULF $6.03
- NVAX $17.83
- AVG Volume (30 Days)
- WULF 26.6M
- NVAX 7.2M
- Earning Date
- WULF 11-12-2024
- NVAX 11-07-2024
- Dividend Yield
- WULF N/A
- NVAX N/A
- EPS Growth
- WULF N/A
- NVAX N/A
- EPS
- WULF N/A
- NVAX N/A
- Revenue
- WULF $120,247,000.00
- NVAX $987,667,000.00
- Revenue This Year
- WULF $129.08
- NVAX N/A
- Revenue Next Year
- WULF $87.70
- NVAX N/A
- P/E Ratio
- WULF N/A
- NVAX N/A
- Revenue Growth
- WULF 197.49
- NVAX N/A
- 52 Week Low
- WULF $0.89
- NVAX $3.53
- 52 Week High
- WULF $7.28
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- WULF 69.41
- NVAX 36.20
- Support Level
- WULF $6.41
- NVAX $9.52
- Resistance Level
- WULF $7.28
- NVAX $10.63
- Average True Range (ATR)
- WULF 0.55
- NVAX 0.57
- MACD
- WULF 0.17
- NVAX -0.12
- Stochastic Oscillator
- WULF 82.04
- NVAX 9.97
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.